Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome

References

• Diamanti-Kandarakis E, Kouli C R, Bergiele A T, Filandra F A, Tsianateli T C, Spina G G, Zapanti E D, Bartzis M I. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006–4011
   PubMed Web of Science ®Google Scholar
• Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres Clin Endocrinol Metab 1996; 10: 221–247
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28: 341–359
   PubMed Web of Science ®Google Scholar
• Urbanek M, Legro R S, Driscoll D A, Azziz R, Ehrmann D A, Norman R J, Strauss J F, III, Spielman R S, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999; 96: 8573–8578
   PubMed Web of Science ®Google Scholar
• Xita N, Georgiou I, Tsatsoulis A. The genetic basis of polycystic ovary syndrome. Eur J Endocrinol 2002; 147: 717–725
   PubMed Web of Science ®Google Scholar
• Ehrmann D A, Tang X, Yoshiuchi I, Cox N J, Bell G I. Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 4297–4300
   PubMed Web of Science ®Google Scholar
• Franks S, Gharani N, McCarthy M. Candidate genes in polycystic ovary syndrome. Hum Reprod Update 2001; 7: 405–410
   PubMed Web of Science ®Google Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861
   PubMed Web of Science ®Google Scholar
• Grant S F, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320–323
   PubMed Web of Science ®Google Scholar
• Helgason A, Palsson S, Thorleifsson G, Grant S F, Emilsson V, Gunnarsdottir S, Adeyemo A, Chen Y, Chen G, Reynisdottir I, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007; 39: 218–225
   PubMed Web of Science ®Google Scholar
• The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Koliopoulos C, Creatsas G. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertil Steril 2002; 77: 919–927
   PubMed Web of Science ®Google Scholar
• Morley J E, Patrick P, Perry H M, 3rd. Evaluation of assays available to measure free testosterone. Metabolism 2002; 51: 554–559
   PubMed Web of Science ®Google Scholar
• Johansen A, Jensen D P, Bergholdt R, Mortensen H B, Pociot F, Nerup J, Hansen T, Pedersen O. Danish Society of Childhood Diabetes. IRS1, KCNJ11, PPARγ2 and HNF-1α: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?. Diabetes Obes Metab 2006; 8: 75–82
   PubMed Web of Science ®Google Scholar
• Barber T M, Bennett A J, Groves C J, Sovio U, Ruokonen A, Martikainen H, Pouta A, Hartikainen A L, Elliott P, Wass J A, et al. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. Diabetologia 2007; 50: 2318–2322
   PubMed Web of Science ®Google Scholar
• Barber T M, Bennett A J, Gloyn A L, Groves C J, Sovio U, Ruokonen A, Martikainen H, Pouta A, Taponen S, Weedon M N, et al. Relationship between E23K (an established type II diabetes-susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels. Eur J Hum Genet 2007; 15: 679–684
   Google Scholar
• Zeggini E, McCarthy M I. TCF7L2: the biggest story in diabetes genetics since HLA?. Diabetologia 2007; 50: 1–4
   PubMed Web of Science ®Google Scholar
• Florez J C, Jablonski K A, Bayley N, Pollin T I, de Bakker P I, Shuldiner A R, Knowler W C, Nathan D M, Altshuler D. Diabetes Prevention Program Research Group. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 2006; 355: 241–250
   PubMed Web of Science ®Google Scholar
• Schwanstecher C, Neugebauer B, Schulz M, Schwanstecher M. The common single nucleotide polymorphism E23K in K(IR)6.2 sensitizes pancreatic β-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphates. Diabetes 2002; 51: S363–S367
   Google Scholar